Colon cancer and apoptosis

American Journal of Surgery

Volumn 191, Issue 4, 2006, Pages 517-526

  Huerta, Sergio ^a   Goulet, Emily J ^a   Livingston, Edward H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apc; Bak; BAX; Bcl 2; Bcl xL; c FLIP; Caspase; Fas; IAPs; NF B; p53; Smac DIABLO; Survivin; TRAIL

Indexed keywords

CASPASE 10; CASPASE 11; CASPASE 12; CASPASE 13; CASPASE 14; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; DEATH RECEPTOR; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CANCER; HUMAN; IMMUNOREGULATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS;

EID: 33644931093     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.11.009     Document Type: Review

References (103)

1. A. Jemal, T. Murray, E. Ward Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
2. T. Watanabe, T.T. Wu, P.J. Catalano Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med 344 2001 1196 1206
3. W. Scheithauer, H. Rosen, G.V. Kornek Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer Br Med J 306 1993 752 755
4. J.A. Meyerhardt, R.J. Mayer Systemic therapy for colorectal cancer N Engl J Med 352 2005 476 487
5. Z.G. Zhang, A. Harstrick, Y.M. Rustum Modulation of fluoropyrimidines role of dose and schedule of leucovorin administration Semin Oncol 19 1992 10 15
6. A. de Gramont, A. Figer, M. Seymour Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
7. C.S. Fuchs Current and ongoing trials with irinotecan in the United States Semin Oncol 30 2003 9 17
8. L. Iyer, M.J. Ratain Clinical pharmacology of camptothecins Cancer Chemother Pharmacol 42 suppl 1998 S31 S43
9. R.M. Goldberg, D.J. Sargent, R.F. Morton A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 2004 23 30
10. E. Raymond, S. Faivre, J.M. Woynarowski Oxaliplatin mechanism of action and antineoplastic activity Semin Oncol 25 1998 4 12
11. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
12. M.C. Cummings, C.M. Winterford, N.I. Walker Apoptosis Am J Surg Pathol 21 1997 88 101
13. J.F. Kerr, A.H. Wyllie, A.R. Currie Apoptosis a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
14. T. Subramanian, G. Chinnadurai Pro-apoptotic activity of transiently expressed BCL-2 occurs independent of BAX and BAK J Cell Biochem 89 2003 1102 1114
15. C. Borner, L. Monney Apoptosis without caspases an inefficient molecular guillotine? Cell Death Diff 6 1999 497 507
16. M. Leist, M. Jaattela Four deaths and a funeral from caspases to alternative mechanisms Nat Rev Mol Cell Biol 2 2001 589 598
17. P.H. Krammer CD95's deadly mission in the immune system Nature 407 2000 789 795
18. H. Walczak, P.H. Krammer The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems Exp Cell Res 256 2000 58 66
19. C. Adrain, S.J. Martin The mitochondrial apoptosome a killer unleashed by the cytochrome seas Trends Biochem Sci 26 2001 390 397
20. D. Chauhan, T. Hideshima, S. Rosen Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells J Biol Chem 276 2001 24453 24456
21. S. Sperandio, I. de Belle, D.E. Bredesen An alternative, nonapoptotic form of programmed cell death Proc Natl Acad Sci USA 97 2000 14376 14381
22. C. Du, M. Fang, Y. Li Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
23. M.W. Mayo, A.S. Baldwin The transcription factor NF-kappaB control of oncogenesis and cancer therapy resistance Biochim Biophys Acta 1470 2000 M55 M62
24. R. Hakem, A. Hakem, G.S. Duncan Differential requirement for caspase 9 in apoptotic pathways in vivo Cell 94 1998 339 352
25. H. Yoshida, Y.Y. Kong, R. Yoshida Apaf1 is required for mitochondrial pathways of apoptosis and brain development Cell 94 1998 739 750
26. E.E. Varfolomeev, M. Schuchmann, V. Luria Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors Fas/Apo1 and DR3 and is lethal prenatally Immunity 9 1998 267 276
27. W.C. Yeh, J.L. Pompa, M.E. McCurrach FADD essential for embryo development and signaling from some, but not all, inducers of apoptosis Science 279 1998 1954 1958
28. S. Roy, D.W. Nicholson Cross-talk in cell death signaling J Exp Med 192 2000 21 26
29. E.A. Slee, C. Adrain, S.J. Martin Serial killers ordering caspase activation events in apoptosis Cell Death Differ 6 1999 1067 1074
30. M. Jaattela Escaping cell death survival proteins in cancer Exp Cell Res 248 1999 30 43
31. B. Zhivotovsky, S. Orrenius Defects in the apoptotic machinery of cancer cells role in drug resistance Semin Cancer Biol 13 2003 125 134
32. L.E. Broker, F.A. Kruyt, G. Giaccone Cell death independent of caspases a review Clin Cancer Res 11 2005 3155 3162
33. T.J. McDonnell Cell division versus cell death a functional model of multistep neoplasia Mol Carcinog 8 1993 209 213
34. D.M. Hockenbery, M. Zutter, W. Hickey BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death Proc Natl Acad Sci U S A 88 1991 6961 6965
35. L.M. Butler, P.J. Hewett, R.A. Fitridge Deregulation of apoptosis in colorectal carcinoma theoretical and therapeutic implications Aust N Z J Surg 69 1999 88 94
36. C. Rupnarain, Z. Dlamini, S. Naicker Colon cancer genomics and apoptotic events Biol Chem 385 2004 449 464
37. M. Anti, A. Armuzzi, S. Morini Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas Gut 48 2001 238 246
38. A. Bedi, P.J. Pasricha, A.J. Akhtar Inhibition of apoptosis during development of colorectal cancer Cancer Res 55 1995 1811 1816
39. C. Greco, S. Alvino, S. Buglioni Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression Anticancer Res 21 2001 3185 3192
40. A.M. Valentini, M.L. Caruso, R. Armentano Programmed cell death in colorectal carcinogenesis Anticancer Res 19 1999 3019 3024
41. N. Hawkins, J. Lees, R. Hargrave Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia Tumour Biol 18 1997 146 156
42. M. Koike Significance of spontaneous apoptosis during colorectal tumorigenesis J Surg Oncol 62 1996 97 108
43. J. O'Connell, M.W. Bennett, K. Nally Altered mechanisms of apoptosis in colon cancer Fas resistance and counterattack in the tumor-immune conflict Ann N Y Acad Sci 910 2000 178 192
44. C.M. Van Geelen, E.G. de Vries, S. de Jong Lessons from TRAIL-resistance mechanisms in colorectal cancer cells paving the road to patient-tailored therapy Drug Resist Updat 7 2004 345 358
45. N. Itoh, S. Yonehara, A. Ishii The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 66 1991 233 243
46. J. O'Connell, M.W. Bennett, G.C. O'Sullivan Fas ligand expression in primary colon adenocarcinomas evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer J Pathol 186 1998 240 246
47. P. Moller, K. Koretz, F. Leithauser Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium Int J Cancer 57 1994 371 377
48. S.R. Wiley, K. Schooley, P.J. Smolak Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
49. J.J. Koornstra, J.H. Kleibeuker, C.M. Van Geelen Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas J Pathol 200 2003 327 335
50. J. Strater, U. Hinz, H. Walczak Expression of TRAIL and TRAIL receptors in colon carcinoma TRAIL-R1 is an independent prognostic parameter Clin Cancer Res 8 2002 3734 3740
51. T.S. Griffith, W.A. Chin, G.C. Jackson Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells J Immunol 161 1998 2833 2840
52. J. Strater, H. Walczak, T. Pukrop TRAIL and its receptors in the colonic epithelium a putative role in the defense of viral infections Gastroenterology 122 2002 659 666
53. K. Takeda, M.J. Smyth, E. Cretney Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development J Exp Med 195 2002 161 169
54. M. Ilyas, J. Straub, I.P. Tomlinson Genetic pathways in colorectal and other cancers Eur J Cancer 35 1999 1986 2002
55. H. LeBlanc, D. Lawrence, E. Varfolomeev Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax Nat Med 8 2002 274 281
56. J.M. Cummins, M. Kohli, C. Rago X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells Cancer Res 64 2004 3006 3008
57. A. Krueger, S. Baumann, P.H. Krammer FLICE-inhibitory proteins regulators of death receptor-mediated apoptosis Mol Cell Biol 21 2001 8247 8254
58. Longley DB, Wilson TR, McEwan M, et al. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death. Oncogene [advance online publication]. Available at: http://www.nature.com/onc/journal/vaop/ncurrent/abs/ 1209122a.html. Accessed January 9, 2005.
59. T. Kataoka, R.C. Budd, N. Holler The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways Curr Biol 10 2000 640 648
60. M. Naito, R. Katayama, T. Ishioka Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt signaling Mol Cell Biol 24 2004 8418 8427
61. K.H. Vousden Activation of the p53 tumor suppressor protein Biochim Biophys Acta 1602 2002 47 59
62. A. Forslund, C. Lonnroth, M. Andersson Mutations and allelic loss of p53 in primary tumor DNA from potentially cured patients with colorectal carcinoma J Clin Oncol 19 2001 2829 2836
63. P. Shaw, R. Bovey, S. Tardy Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line Proc Natl Acad Sci USA 89 1992 4495 4499
64. A. Fazeli, R.G. Steen, S.L. Dickinson Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas Proc Natl Acad Sci USA 94 1997 10199 10204
65. P. Lassus, X. Opitz-Araya, Y. Lazebnik Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization Science 297 2002 1352 1354
66. M. Jiang, J. Milner Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells Genes Dev 17 2003 832 837
67. H.A. Saleh, H. Jackson, M. Banerjee Immunohistochemical expression of bcl-2 and p53 oncoproteins correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia Appl Immunohistochem Mol Morphol 8 2000 175 182
68. W.H. Hoffman, S. Biade, J.T. Zilfou Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 J Biol Chem 277 2002 3247 3257
69. R. Fodde, R. Smits, H. Clevers APC, signal transduction and genetic instability in colorectal cancer Nat Rev Cancer 1 2001 55 67
70. T. Senda, A. Shimomura, A. Iizuka-Kogo Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene Anat Sci Int 80 2005 121 131
71. T.C. He, A.B. Sparks, C. Rago Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
72. M. Krajewska, S.F. Moss, S. Krajewski Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas Cancer Res 56 1996 2422 2427
73. A.J. Watson, A.J. Merritt, L.S. Jones Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas Br J Cancer 73 1996 889 895
74. I. Sturm, C.H. Kohne, G. Wolff Analysis of the p53/BAX pathway in colorectal cancer low BAX is a negative prognostic factor in patients with resected liver metastases J Clin Oncol 17 1999 1364 1374
75. L. Zhang, J. Yu, B.H. Park Role of BAX in the apoptotic response to anticancer agents Science 290 2000 989 992
76. S. Violette, L. Poulain, E. Dussaulx Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status Int J Cancer 98 2002 498 504
77. R. Ravi, A. Bedi Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers synergism with sulindac-mediated inhibition of Bcl-x(L) Cancer Res 62 2002 1583 1587
78. L. Sevilla, A. Zaldumbide, P. Pognonec Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families Histol Histopathol 16 2001 595 601
79. J.C. Cusack Jr Overcoming antiapoptotic responses to promote chemosensitivity in metastatic colorectal cancer to the liver Ann Surg Oncol 10 2003 852 862
80. H. Kawasaki, D.C. Altieri, C.D. Lu Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res 58 1998 5071 5074
81. N.S. Williams, R.B. Gaynor, S. Scoggin Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference Clin Cancer Res 9 2003 931 946
82. A.I. Sarela, N. Scott, J. Ramsdale Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas Ann Surg Oncol 8 2001 305 310
83. Y. Yamamoto, M.J. Yin, K.M. Lin Sulindac inhibits activation of the NF-kappaB pathway J Biol Chem 274 1999 27307 27314
84. T. Zhang, J.Z. Fields, S.M. Ehrlich The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells J Pharmacol Exp Ther 308 2004 434 437
85. Y. Fujie, H. Yamamoto, C.Y. Ngan Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells Jpn J Clin Oncol 35 2005 453 463
86. A. Urbano, U. Lakshmanan, P.H. Choo AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells EMBO J 24 2005 2815 2826
87. T. Onoda, T. Ono, D.K. Dhar Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells Int J Cancer 118 2005 in press
88. Y.C. Park, J.H. Jeong, K.J. Park Sulindac activates nuclear translocation of AIF, DFF40 and endonuclease G but not induces oligonucleosomal DNA fragmentation in HT-29 cells Life Sci 77 2005 2059 2070
89. L.M. Erhart, B. Lankat-Buttgereit, H. Schmidt Flavone initiates a hierarchical activation of the caspase-cascade in colon cancer cells Apoptosis 10 2005 611 617
90. S. Basu, R. Kolesnick Stress signals for apoptosis ceramide and c-Jun kinase Oncogene 17 1998 3277 3285
91. Y. Lavie, H. Cao, S.L. Bursten Accumulation of glucosylceramides in multidrug-resistant cancer cells J Biol Chem 271 1996 19530 19536
92. F.M. Ruemmele, S. Schwartz, E.G. Seidman Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway Gut 52 2003 94 100
93. Y.H. Kim, J.W. Park, J.Y. Lee Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells Carcinogenesis 25 2004 1813 1820
94. C.P. Schroder, H.R. Maurer Tributyrin-induced differentiation promotes apoptosis of LS 174T colon cancer cells in vitro Int J Oncol 20 2002 195 200
95. A. Jarry, G. Vallette, E. Cassagnau Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer Gut 45 1999 246 251
96. I. Shureiqi, W. Jiang, X. Zuo The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells Proc Natl Acad Sci USA 100 2003 9968 9973
97. P.A. Janne, R.J. Mayer Chemoprevention of colorectal cancer N Engl J Med 342 2000 1960 1968
98. S.E. Holt, J.W. Shay Role of telomerase in cellular proliferation and cancer J Cell Physiol 180 1999 10 18
99. S. Kondo, Y. Tanaka, Y. Kondo Antisense telomerase treatment induction of two distinct pathways, apoptosis and differentiation FASEB J 12 1998 801 811
100. Y. Kakugawa, T. Wada, K. Yamaguchi Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression Proc Natl Acad Sci USA 99 2002 10718 10723
101. C.V. Rao Nitric oxide signaling in colon cancer chemoprevention Mutat Res 555 2004 107 119
102. H.H. Backus, C.J. Van Groeningen, W. Vos Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases J Clin Pathol 55 2002 206 211
103. B. Mann, A. Gratchev, C. Bohm FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas Br J Cancer 79 1999 1262 1269